Targeting gold at the end of the rainbow: Surgical gamma probes in the 21st century

Journal of Surgical Oncology

Volumn 96, Issue 4, 2007, Pages 286-289

  Moffat Jr , Frederick L ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Radioimmunoguided surgery; Sentinel node biopsy; Tumor to background ratio

Indexed keywords

CADMIUM DERIVATIVE; CADMIUM TELLURIDE; CADMIUM ZINC TELLURIDE; CARCINOEMBRYONIC ANTIBODY; COLLOIDAL GOLD; FLUORODEOXYGLUCOSE F 18; IODINE 131; MERCURIC IODIDE; PHOSPHATE; PHOSPHORUS 32; SODIUM IODIDE; TECHNETIUM 99M; TELLURIUM DERIVATIVE; TUMOR MARKER; UNCLASSIFIED DRUG; ZINC DERIVATIVE; ANTIBODY CONJUGATE; DIAGNOSTIC AGENT;

CANCER; CANCER SURGERY; COMPTON EFFECT; DOSIMETRY; ELECTRON; HUMAN; ISOTOPE LABELING; MEASUREMENT; MECHANICAL PROBE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PHYSICS; REVIEW; SCINTILLATION CAMERA; SENTINEL LYMPH NODE BIOPSY; SIGNAL DETECTION; TUMOR TO BACKGROUND RATIO; COMPUTER ASSISTED SURGERY; INSTRUMENTATION; NEOPLASM; RADIOIMMUNOASSAY; SCINTISCANNING;

GAMMA CAMERAS; HUMANS; IMMUNOCONJUGATES; NEOPLASMS; RADIOIMMUNODETECTION; SENTINEL LYMPH NODE BIOPSY; SURGERY, COMPUTER-ASSISTED;

EID: 34848850435     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20861     Document Type: Review

References (16)

1. Selverstone B, Sweet WH, Robinson CV: The clinical use of radioactive phosphorus in the surgery of brain tumors. Ann Surg 1949;136:643-651.
2. Selverstone B, Solomon AK, Sweet WH: Location of brain tumors by means of radioactive phosphorus. J Am Med Assoc 1949;140:277-278.
3. Harris CC, Bigelow RR, Francis JE, et al.: A CsI(T1) - crystal scintillation probe. Nucleonics 1956;14:104-108.
4. Aitken DR, Hinkle GH, Thurston MO, et al.: A gamma-detecting probe for radioimmune detection of CEA-producing tumors. Dis Colon Rectum 1984;27:279-282.
5. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
6. Alex JC, Krag DN: Gamma-probe guided localization of lymph nodes. Surg Oncol 1993;2:137-143.
7. Alex JC, Weaver DL, Fairbank JT, et al.: Gamma-probe guided lymph node localization in malignant melanoma. Surg Oncol 1993;2:203-208.
8. Gulec SA, Moffat FL, Carroll RG: The expanding role for intraoperative gamma probes. In: Freeman LM, editor. Nuclear medicine annual. Philadelphia: Lippincott-Raven; 1997. pp. 209-237.
9. Mariant G, Vaiano A, Nibale O, et al.: Is the "ideal" γ-probe for intraoperative radioguided surgery conceivable? J Nucl Med 2005;46:388-390.
10. Waddington WA, Davidson DR, Todd-Pokropek A, et al.: Evaluation of a technique for the intraoperative detection of a radiolabeled monoclonal antibody against colorectal cancer. Eur J Nucl Med 1991;18:964-972.
11. Hinkle GH, Mojzisik CM, Loesch JA, et al.: The evolution of the radioimmunoguided system: An innovative technique for the intraoperative detection of tumor. Antibody Immunoconj Radiopharm 1991;4:339-358.
12. Arnold MW, Schneebaum S, Berens A, et al.: Radioimmunoguided surgery challenges traditional decision-making in patients with primary colorectal cancer. Surgery 1992;112:624-630.
13. Moffat FL, Gulec SA, Serafini AN, et al.: A thousand;points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging. Cancer Invest 1999;17:322-334.
14. Sharkey RM: The direct route may not be the best way to home. J Nucl Med 2005;46:391-394.
15. van't Veer LJ, Dai H, van de Vijver MJ, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
16. van de Vijver MJ, He YD, van't Veer LJ, et al.: A gene expression signature as a predictor of survival in breast cancer. New Engl J Med 2002;347:1999-2009.